M. Castiglione
- Cancer Research top 0.5%
- Breast Cancer Treatment Studies 23
- Oncology top 0.5%
- Cancer Treatment and Pharmacology 11
- HER2/EGFR in Cancer Research 7
- Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment 7
-
- Breast Lesions and Carcinomas 8
- Obstetrics and Gynecology top 2%
- Endometrial and Cervical Cancer Treatments 6
-
- Estrogen and related hormone effects 6
-
- Advanced Breast Cancer Therapies 4
- Co-authors
- Stefan AebiGünther GruberT. DavidsonFátima CardosoElżbieta SenkusLesley FallowfieldA. CostaRichard D. Gelber
- Partner nations
- SwitzerlandItalyUnited Kingdom
In The Last Decade
M. Castiglione
41 papers receiving 4.8k citations
Hit Papers
Peers
Comparison fields: 5 of 121
- Cancer Research 2.5k
- Oncology 2.8k
- Reproductive Medicine 442
- Pathology and Forensic Medicine 786
- Obstetrics and Gynecology 276
Countries citing papers authored by M. Castiglione
This map shows the geographic impact of M. Castiglione's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Castiglione with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Castiglione more than expected).
Fields of papers citing papers by M. Castiglione
This network shows the impact of papers produced by M. Castiglione. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Castiglione. The network helps show where M. Castiglione may publish in the future.
Co-authorship network
The 25 scholars most cited alongside M. Castiglione, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2011 | 497 | |
| 5 | 2010 | 164 | |
| 6 | 2010 | 146 | |
| 7 | 2010 | 87 | |
| 8 | 2010 | 81 | |
| 9 | Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upbreakdown → | 2010 | 2452 |
| 10 | 2009 | 65 | |
| 11 | 2009 | 26 | |
| 12 | 2009 | 97 | |
| 13 | 2009 | 39 | |
| 14 | 2008 | 45 | |
| 15 | 1997 | 9 | |
| 16 | 1996 | 9 | |
| 17 | 1994 | 115 | |
| 18 | 1992 | 18 | |
| 19 | 1992 | 47 | |
| 20 | 1988 | 98 |
About M. Castiglione
M. Castiglione is a scholar working on Cancer Research, Oncology and Reproductive Medicine, having authored 48 papers that have together received 5.0k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (23 papers), Cancer Treatment and Pharmacology (11 papers), Breast Lesions and Carcinomas (8 papers), Ovarian cancer diagnosis and treatment (7 papers), HER2/EGFR in Cancer Research (7 papers), Endometrial and Cervical Cancer Treatments (6 papers), Estrogen and related hormone effects (6 papers) and Advanced Breast Cancer Therapies (4 papers). The work is most often cited by research in Cancer Research (2.5k citations), Oncology (2.8k citations) and Reproductive Medicine (442 citations). M. Castiglione has collaborated with scholars based in Switzerland, Italy and United Kingdom. Frequent co-authors include Stefan Aebi, Günther Gruber, T. Davidson, Fátima Cardoso, Elżbieta Senkus, Lesley Fallowfield, A. Costa, Richard D. Gelber, Aron Goldhirsch and Vesa Kataja. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.